April 7, 2014

Eli Lilly intensifies efforts to stop fake pharmaceuticals

  OUR LATEST ON TWITTER

Global Innovation Policy Center @globalIPcenter 19m

“It was because of a strong #patent system that we were even able to manufacture and develop this vaccine in the first place.” @Pfizer’s Angela Hwang emphasizes the importance of a strong #IP system to EU lawmakers in a public hearing. More here. https://t.co/rDP3mHRDy9

Reply Retweet Favorite


Subscribe for updates from GIPC